R&D

Rapid Test Development

Part of our growth strategy is to innovative products and solutions and meet our customers’ increasingly stringent quality requirements. We continuously invest in optimizing production and product quality as well as in our product portfolio, working closely with our customers and partners from industry, universities, and other institutions.

15 Sep 2020

Biosensor Development

As a powerful tool in bioanalysis, immunoassays rely on the specific reaction between an antigen and a selective antibody and use different labels such as radioactive isotopes, enzymes, and fluorophores for signal development. In recent years, due to their superior optical or electrochemical properties and substantially greater chemical stability, nanomaterials are increasingly taking place of those molecular tags. There are many magnetic particles- and nanoparticle-based immunoassays and biosensors developed to detect various targets (e.g., cells, proteins, pathogens, and small molecular toxins).

15 Sep 2020

Device Development

What are we aiming for? Early diagnosis of diseases is very important in terms of treatment and prevention of spread. The more accessible and cost-effective diagnostic devices are, reach a wide mass of people. as the CHIL family device development department we are taking these issues into account in all products we develop. We continue to develop low-cost portable devices that perform fast and high-precision analysis.

15 Sep 2020

You might be interested in

Document Center

Search Result

Home

Highlights

About Us

Highlights

About Us

Products

Highlights

Products

R&D

Highlights

R&D

Partnering

Suppliers

Sustainability

Blog

Highlights

Blog

Career

Help Center

Highlights

Help Center

Contact

R&D

Rapid Test Development

Biosensor Development

Device Development

You might be interested in